BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8627553)

  • 1. Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.
    Holtzman SG
    J Pharmacol Exp Ther; 1996 May; 277(2):739-46. PubMed ID: 8627553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    Howell LL; Byrd LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):432-9. PubMed ID: 8229772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.
    Holtzman SG
    Eur J Pharmacol; 1999 Jul; 376(1-2):7-15. PubMed ID: 10440083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
    Coffin VL; Spealman RD
    J Pharmacol Exp Ther; 1985 Dec; 235(3):724-8. PubMed ID: 2416907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation.
    Holtzman SG
    J Pharmacol Exp Ther; 1986 Dec; 239(3):706-14. PubMed ID: 2432216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.
    Spealman RD
    Psychopharmacology (Berl); 1988; 95(1):19-24. PubMed ID: 3133696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
    Richter A; Hamann M
    Br J Pharmacol; 2001 Sep; 134(2):343-52. PubMed ID: 11564652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of methylxanthines and their metabolites in rats.
    Carney JM; Holloway FA; Modrow HE
    Life Sci; 1985 Mar; 36(10):913-20. PubMed ID: 3974401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.
    Griebel G; Saffroy-Spittler M; Misslin R; Remmy D; Vogel E; Bourguignon JJ
    Psychopharmacology (Berl); 1991; 103(4):541-4. PubMed ID: 2062988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic effects of xanthines on levels of central receptors in mice.
    Shi D; Daly JW
    Cell Mol Neurobiol; 1999 Dec; 19(6):719-32. PubMed ID: 10456233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
    Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
    Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
    Jarvis MF; Williams M; Do UH; Sills MA
    Mol Pharmacol; 1991 Jan; 39(1):49-54. PubMed ID: 1987452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
    Kuzmin A; Johansson B; Zvartau EE; Fredholm BB
    J Pharmacol Exp Ther; 1999 Aug; 290(2):535-42. PubMed ID: 10411560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
    Felsch A; Stöcker K; Borchard U
    Eur J Pharmacol; 1994 Oct; 263(3):261-8. PubMed ID: 7843263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
    Karcz-Kubicha M; Antoniou K; Terasmaa A; Quarta D; Solinas M; Justinova Z; Pezzola A; Reggio R; Müller CE; Fuxe K; Goldberg SR; Popoli P; Ferré S
    Neuropsychopharmacology; 2003 Jul; 28(7):1281-91. PubMed ID: 12700682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    Fredholm BB; Lindström K
    Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline.
    Coffin VL; Spealman RD
    Eur J Pharmacol; 1989 Oct; 170(1-2):35-40. PubMed ID: 2482186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.